Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Invitae Corp | Director | Common Stock | 125K | $81.2K | $0.65 | Apr 27, 2023 | Direct |
Biomea Fusion, Inc. | Director | Stock Option (Right to Buy) | 51K | Jun 12, 2024 | Direct | ||
Invitae Corp | Director | Stock Option (right to buy) | 28.9K | Apr 27, 2023 | Direct | ||
BridgeBio Pharma, Inc. | Director | Stock Option (Right to Buy) | 26K | Jun 21, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
BBIO | BridgeBio Pharma, Inc. | Jun 21, 2024 | 1 | $0 | 4 | Jun 25, 2024 | Director |
BMEA | Biomea Fusion, Inc. | Jun 12, 2024 | 1 | $0 | 4 | Jun 13, 2024 | Director |
BBIO | BridgeBio Pharma, Inc. | Jun 21, 2023 | 1 | $0 | 4 | Jun 23, 2023 | Director |
BMEA | Biomea Fusion, Inc. | Jun 14, 2023 | 1 | $0 | 4 | Jun 16, 2023 | Director |
NVTA | Invitae Corp | Apr 27, 2023 | 2 | $0 | 4 | May 1, 2023 | Director |
BMEA | Biomea Fusion, Inc. | Jun 22, 2022 | 1 | $0 | 4 | Jun 24, 2022 | Director |
BBIO | BridgeBio Pharma, Inc. | Jun 22, 2022 | 1 | $0 | 4 | Jun 24, 2022 | Director |
NVTA | Invitae Corp | Apr 28, 2022 | 4 | $0 | 4 | May 2, 2022 | Director |
BBIO | BridgeBio Pharma, Inc. | Jun 17, 2021 | 1 | $0 | 4 | Jun 22, 2021 | Director |